Key result
SMBP use among Medicaid enrollees spiked during the pandemic and remains above pre-pandemic levels.
Why the study?
SMBP monitoring effectively lowers blood pressure in hypertension with positive impacts on health equity, but trends in its utilization among Medicaid enrollees needed evaluation.
Observational
Yes
Self-measured blood pressure monitoring utilization among Medicaid enrollees increased during the pandemic and remains above pre-pandemic levels, highlighting sustained adoption but significant state-level disparities.
Sustained Medicaid self-measured BP adoption may guide program planning; leaves open drivers of state disparities and outcome effects.
Introduction: When coupled with clinical supports, self-measured blood pressure (SMBP) monitoring has been shown to be effective at lowering blood pressure for people with hypertension, with positive impacts on health equity. Methods: This analysis uses nationwide Medicaid claims data to examine trends in SMBP use (ie, use of SMBP services and/or devices) at the national and state levels from 2018 to 2022 among adult Medicaid enrollees. Results: Rates of SMBP use spiked during the pandemic and subsequently decreased, although rates are still higher than those observed pre-pandemic, and utilization varied considerably by state. Conclusion: Future research should seek to improve understanding of factors driving state variation in SMBP use.
No takes yet. Share an insight, caveat, or question.
Pauly et al. (2025) conducted an observational in Hypertension. Self-measured blood pressure (SMBP) monitoring was evaluated on Trends in SMBP use (services and/or devices). Self-measured blood pressure use among adult Medicaid enrollees spiked during the pandemic and remained higher than pre-pandemic levels, with considerable state-level variation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: